Russia's Gamaleya Institute Completing Phase 2 Trials of Sputnik Light Single-Shot Vaccine

MOSCOW (Sputnik) - Russia's Gamaleya research institute is completing the second phase of clinical trials of the Sputnik Light vaccine against the coronavirus, institute chief Alexander Gintsburg said on Friday.

Russia's Gamaleya Institute Completing Phase 2 Trials of Sputnik Light Single-Shot Vaccine
MOSCOW (Sputnik) - Russia's Gamaleya research institute is completing the second phase of clinical trials of the Sputnik Light vaccine against the coronavirus, institute chief Alexander Gintsburg said on Friday.